Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor. Colombia Medica, [S. l.], v. 47, n. 4, p. 196–202, 2016. DOI: 10.25100/cm.v47i4.1989. Disponível em: https://colombiamedica.univalle.edu.co/index.php/comedica/article/view/1989. Acesso em: 2 jan. 2026.